Arnaud Glacet

Chronic lymphocytic leukaemia cells are efficiently killed by an anti‐CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16

Christophe de Romeuf, Charles‐Antoine Dutertre, Magali Le Garff‐Tavernier et al. · British Journal of Haematology · 2008 · 118 citations

Pharmacy, Immunology, Oncology +17

Selection of a human anti-RhD monoclonal antibody for therapeutic use: Impact of IgG glycosylation on activating and inhibitory FcγR functions

Sophie Sibéril, Christophe de Romeuf, Nicolas Bihoreau et al. · Clinical Immunology · 2005 · 87 citations

Pharmacy, Immunology, Antibody Engineering +16

Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties

Denis Cointe, R Béliard, Sylvie Jorieux et al. · Glycobiology · 2000 · 37 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

In vivo biotinylated recombinant antibodies: high efficiency of labelling and application to the cloning of active anti-human IgG1 Fab fragments

Annie‐Paule Sibler, Emmanuelle Kempf, Arnaud Glacet et al. · Journal of Immunological Methods · 1999 · 25 citations

Pharmacy, Biotechnology, Molecular Biology +13

Use of the DAF Assay to Assess the Functional Properties of Polyclonal and Monoclonal Rh D Antibodies

Thierry Ducrot, R Béliard, Arnaud Glacet et al. · Vox Sanguinis · 1996 · 12 citations

Life Sciences, Immunology, Clinical Immunology +15